Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5% Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 Jun. 15];4(6):s91. Available from: https://skin.dermsquared.com/skin/article/view/1061